PMID- 21487760 OWN - NLM STAT- MEDLINE DCOM- 20111024 LR - 20231213 IS - 1573-2665 (Electronic) IS - 0141-8955 (Linking) VI - 34 IP - 3 DP - 2011 Jun TI - Defect in proline synthesis: pyrroline-5-carboxylate reductase 1 deficiency leads to a complex clinical phenotype with collagen and elastin abnormalities. PG - 731-9 LID - 10.1007/s10545-011-9319-3 [doi] AB - Pyrroline-5-carboxylate reductase 1 (PYCR1) catalyzes the last step in proline synthesis. Deficiency of PYCR1, caused by a defect in PYCR1, was recently described in patients with cutis laxa, intrauterine growth retardation, developmental dysplasia of the hips and mental retardation. In this paper, we describe additional six patients (ages ranging from 4 months to 55 years) from four Iranian families with clinical manifestations of a wrinkly skin disorder. All patients have distinct facial features comprising triangular face, loss of adipose tissue and thin pointed nose. Additional features are short stature, wrinkling over dorsum of hand and feet, visible veins over the chest and hyperextensible joints. Three of the patients from a large consanguineous family do not have mental retardation, while the remaining three patients from three unrelated families have mental and developmental delay. Mutation analysis revealed the presence of disease-causing variants in PYCR1, including a novel deletion of the entire PYCR1 gene in one family, and in each of the other patients the homozygous missense mutations c.616G > A (p.Gly206Arg), c.89T > A (p.Ile30Lys) and c.572G > A (p.Gly191Glu) respectively, the latter two of which are novel. Light- and electron microscopy investigations of skin biopsies showed smaller and fragmented elastic fibres, abnormal morphology of the mitochondria and their cristae, and slightly abnormal collagen fibril diameters with irregular outline and variable size. In conclusion, this study adds information on the natural course of PYCR1 deficiency and sheds light on the pathophysiology of this disorder. However, the exact pathogenesis of this new disorder and the role of proline in the development of the clinical phenotype remain to be fully explained. FAU - Kretz, Rita AU - Kretz R AD - Division of Metabolism, Kinderspital Zurich, Pediatric Research Centre, Steinwiesstrasse 75, 8032 Zurich, Switzerland. FAU - Bozorgmehr, Bita AU - Bozorgmehr B FAU - Kariminejad, Mohamad Hasan AU - Kariminejad MH FAU - Rohrbach, Marianne AU - Rohrbach M FAU - Hausser, Ingrid AU - Hausser I FAU - Baumer, Alessandra AU - Baumer A FAU - Baumgartner, Matthias AU - Baumgartner M FAU - Giunta, Cecilia AU - Giunta C FAU - Kariminejad, Ariana AU - Kariminejad A FAU - Haberle, Johannes AU - Haberle J LA - eng PT - Case Reports PT - Journal Article DEP - 20110413 PL - United States TA - J Inherit Metab Dis JT - Journal of inherited metabolic disease JID - 7910918 RN - 0 (Pyrroles) RN - 2906-39-0 (delta-1-pyrroline-5-carboxylate) RN - 9007-34-5 (Collagen) RN - 9007-58-3 (Elastin) RN - 9DLQ4CIU6V (Proline) RN - EC 1.5.1.- (Pyrroline Carboxylate Reductases) SB - IM MH - Abnormalities, Multiple/*genetics/metabolism MH - Adolescent MH - Adult MH - Child MH - Child, Preschool MH - Collagen/*deficiency/metabolism MH - DNA Mutational Analysis MH - Elastin/*deficiency/metabolism MH - Family MH - Female MH - Humans MH - Infant MH - Male MH - Metabolism, Inborn Errors/complications/*genetics MH - Middle Aged MH - Models, Biological MH - Mutation, Missense MH - Phenotype MH - Proline/biosynthesis/*deficiency MH - Pyrroles/metabolism MH - Pyrroline Carboxylate Reductases/deficiency/*genetics MH - Young Adult MH - delta-1-Pyrroline-5-Carboxylate Reductase EDAT- 2011/04/14 06:00 MHDA- 2011/10/25 06:00 CRDT- 2011/04/14 06:00 PHST- 2011/01/26 00:00 [received] PHST- 2011/03/18 00:00 [accepted] PHST- 2011/03/15 00:00 [revised] PHST- 2011/04/14 06:00 [entrez] PHST- 2011/04/14 06:00 [pubmed] PHST- 2011/10/25 06:00 [medline] AID - 10.1007/s10545-011-9319-3 [doi] PST - ppublish SO - J Inherit Metab Dis. 2011 Jun;34(3):731-9. doi: 10.1007/s10545-011-9319-3. Epub 2011 Apr 13.